Low levels of a natural IgM antibody are associated with vein graft stenosis and failure

Journal of Vascular Surgery

Volumn 58, Issue 4, 2013, Pages

  Sobel, Michael ^a   Moreno, Katherine I ^a   Yagi, Mayumi ^a   Kohler, Ted R ^a   Tang, Gale L ^a   Clowes, Alexander W ^a   Zhou, Xiao Hua A ^b,c   Eugenio, Evercita ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANASTOMOSIS; ANKLE BRACHIAL INDEX; ANTIBODY BLOOD LEVEL; ARTERY RECONSTRUCTION; ARTICLE; BACTERIAL CAPSULE; CARDIOVASCULAR RISK; CLAUDICATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; IMMUNOGLOBULIN M ANTIBODY BLOOD LEVEL; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; VEIN GRAFT; VEIN GRAFT DISEASE; VEIN GRAFT FAILURE; VEIN GRAFT STENOSIS;

EID: 84884905187     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.04.042     Document Type: Article

References (41)

1. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
2. J.F. Keaney Jr. Immune modulation of atherosclerosis Circulation 124 2011 e559 e560
3. L. Badimon, R.F. Storey, and G. Vilahur Update on lipids, inflammation and atherothrombosis Thromb Haemost 105 Suppl 1 2011 S34 S42
4. S. Lee, K.G. Birukov, C.E. Romanoski, J.R. Springstead, A.J. Lusis, and J.A. Berliner Role of phospholipid oxidation products in atherosclerosis Circ Res 111 2012 778 799
5. C.J. Binder, M.K. Chang, P.X. Shaw, Y.I. Miller, K. Hartvigsen, and A. Dewan Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
6. C. Gronwall, J. Vas, and G.J. Silverman Protective roles of natural IgM antibodies Front Immunol 3 2012 66
7. M.R. Ehrenstein, and C.A. Notley The importance of natural IgM: scavenger, protector and regulator Nat Rev Immunol 10 2010 778 786
8. H.U. Lutz, C.J. Binder, and S. Kaveri Naturally occurring auto-antibodies in homeostasis and disease Trends Immunol 30 2009 43 51
9. C.J. Binder Naturally occurring IgM antibodies to oxidation-specific epitopes Adv Exp Med Biol 750 2012 2 13
10. U. de Faire, and J. Frostegard Natural antibodies against phosphorylcholine in cardiovascular disease Ann N Y Acad Sci 1173 2009 292 300
11. Y.I. Miller, S.H. Choi, P. Wiesner, L. Fang, R. Harkewicz, and K. Hartvigsen Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity Circ Res 108 2011 235 248
12. Athera biotechnologies - CVDefine product sheet and references 2013
13. Y. Imai, K. Kuba, G.G. Neely, R. Yaghubian-Malhami, T. Perkmann, and L.G. van Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury Cell 133 2008 235 249
14. U. de Faire, J. Su, X. Hua, A. Frostegard, M. Halldin, and M.L. Hellenius Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism J Autoimmun 34 2010 73 79
15. R. Fiskesund, B. Stegmayr, G. Hallmans, M. Vikstrom, L. Weinehall, and U. de Faire Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden Stroke 41 2010 607 612
16. H. Gronlund, G. Hallmans, J.H. Jansson, K. Boman, M. Wikstrom, and U. de Faire Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden Eur J Cardiovasc Prev Rehabil 16 2009 382 386
17. K. Caidahl, M. Hartford, T. Karlsson, J. Herlitz, K. Pettersson, and U. de Faire IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes Int J Cardiol 167 2013 464 469
18. J.J. Carrero, X. Hua, P. Stenvinkel, A.R. Qureshi, O. Heimburger, and P. Barany Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis Nephrol Dial Transplant 24 2009 3454 3460
19. G. Caligiuri, J. Khallou-Laschet, M. Vandaele, A.T. Gaston, S. Delignat, and C. Mandet Phosphorylcholine-targeting immunization reduces atherosclerosis J Am Coll Cardiol 50 2007 540 546
20. J.R. Faria-Neto, K.Y. Chyu, X. Li, P.C. Dimayuga, C. Ferreira, and J. Yano Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice Atherosclerosis 189 2006 83 90
21. I. Rahman, R. Atout, N.L. Pedersen, U. de Faire, J. Frostegard, and E. Ninio Genetic and environmental regulation of inflammatory CVD biomarkers Lp-PLA2 and IgM anti-PC Atherosclerosis 218 2011 117 122
22. M.S. Conte, D.F. Bandyk, A.W. Clowes, G.L. Moneta, L. Seely, and T.J. Lorenz Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery J Vasc Surg 43 2006 742 751
23. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, and S. Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
24. D.F. Bandyk Infrainguinal vein bypass graft surveillance: how to do it, when to intervene, and is it cost-effective? J Am Coll Surg 194 1 Suppl 2002 S40 S52
25. C.N. Tinder, J.P. Chavanpun, D.F. Bandyk, P.A. Armstrong, M.R. Back, and B.L. Johnson Efficacy of duplex ultrasound surveillance after infrainguinal vein bypass may be enhanced by identification of characteristics predictive of graft stenosis development J Vasc Surg 48 2008 613 618
26. J.L. Mills, C.L. Wixon, D.C.M. James, J. Devine, A. Westerband, and J.D. Hughes The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair J Vasc Surg 33 2001 273 280
27. A.K. Gupta, D.F. Bandyk, D. Cheanvechai, and B.L. Johnson Natural history of infrainguinal vein graft stenosis relative to bypass grafting technique J Vasc Surg 25 1997 211 220
28. K. Visser, M.M. Idu, J. Buth, G.L. Engel, and M.G. Hunink Duplex scan surveillance during the first year after infrainguinal autologous vein bypass grafting surgery: costs and clinical outcomes compared with other surveillance programs J Vasc Surg 33 2001 123 130
29. J.B. Towne, D.D. Schmitt, G.R. Seabrook, and D.F. Bandyk The effect of vein diameter on patency of in situ grafts J Cardiovasc Surg (Torino) 32 1991 192 196
30. M.M. Idu, J. Buth, W.C. Hop, P. Cuypers, E.D. van de Pavoordt, and J.M. Tordoir Factors influencing the development of vein-graft stenosis and their significance for clinical management Eur J Vasc Endovasc Surg 17 1999 15 21
31. K.R. Wengerter, F.J. Veith, S.K. Gupta, E. Ascer, and S.P. Rivers Influence of vein size (diameter) on infrapopliteal reversed vein graft patency J Vasc Surg 11 1990 525 531
32. A. Schanzer, N. Hevelone, C.D. Owens, M. Belkin, D.F. Bandyk, and A.W. Clowes Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial J Vasc Surg 46 2007 1180 1190
33. B.G. Sjoberg, J. Su, I. Dahlbom, H. Gronlund, M. Wikstrom, and B. Hedblad Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men Atherosclerosis 203 2009 528 532
34. J. Su, A. Georgiades, R. Wu, T. Thulin, U. de Faire, and J. Frostegard Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension Atherosclerosis 188 2006 160 166
35. J. Su, X. Hua, H. Concha, E. Svenungsson, A. Cederholm, and J. Frostegard Natural antibodies against phosphorylcholine as potential protective factors in SLE Rheumatology (Oxford) 47 2008 1144 1150
36. F.H. Cesena, P.C. Dimayuga, J. Yano, X. Zhao, J. Kirzner, and J. Zhou Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice Atherosclerosis 220 2012 59 65
37. C.D. Owens, K.J. Ho, and M.S. Conte Lower extremity vein graft failure: a translational approach Vasc Med 13 2008 63 74
38. C.D. Owens Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications J Vasc Surg 51 2010 736 746
39. C.D. Owens, F.J. Rybicki, N. Wake, A. Schanzer, D. Mitsouras, and M.D. Gerhard-Herman Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation J Vasc Surg 47 2008 1235 1242
40. R.P. Chaparala, N.M. Orsi, N.J. Lindsey, R.S. Girn, and S. Homer-Vanniasinkam Inflammatory profiling of peripheral arterial disease Ann Vasc Surg 23 2009 172 178
41. K. Moreno, J. Murray-Wijelath, M. Yagi, T. Kohler, T. Hatsukami, and A. Clowes Circulating inflammatory cells are associated with vein graft stenosis J Vasc Surg 54 2011 1124 1130